IRIS
PERRICONE, ROBERTO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 61.374
AS - Asia 6.771
EU - Europa 6.000
SA - Sud America 923
Continente sconosciuto - Info sul continente non disponibili 749
AF - Africa 142
OC - Oceania 97
Totale 76.056
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 61.015
SG - Singapore 3.092
CN - Cina 1.485
IT - Italia 868
DE - Germania 836
RU - Federazione Russa 815
BR - Brasile 749
UA - Ucraina 700
FR - Francia 601
IE - Irlanda 590
HK - Hong Kong 581
FI - Finlandia 511
VN - Vietnam 485
GB - Regno Unito 366
SE - Svezia 278
BD - Bangladesh 238
CA - Canada 183
JP - Giappone 181
KR - Corea 169
IN - India 111
PL - Polonia 77
NL - Olanda 76
BE - Belgio 64
MX - Messico 64
AU - Australia 53
ID - Indonesia 51
ES - Italia 50
AR - Argentina 47
NZ - Nuova Zelanda 43
ZA - Sudafrica 43
TW - Taiwan 42
DK - Danimarca 37
IQ - Iraq 36
UZ - Uzbekistan 35
TR - Turchia 32
CO - Colombia 31
EC - Ecuador 31
SA - Arabia Saudita 31
IR - Iran 30
PK - Pakistan 30
MY - Malesia 26
PH - Filippine 24
JM - Giamaica 22
AT - Austria 20
EG - Egitto 19
MA - Marocco 19
AE - Emirati Arabi Uniti 18
VE - Venezuela 18
CL - Cile 16
CR - Costa Rica 16
LT - Lituania 16
NP - Nepal 13
RO - Romania 13
HN - Honduras 12
KE - Kenya 12
LV - Lettonia 11
UY - Uruguay 11
CZ - Repubblica Ceca 10
TN - Tunisia 10
TT - Trinidad e Tobago 10
NI - Nicaragua 9
PE - Perù 9
TH - Thailandia 9
ET - Etiopia 8
GR - Grecia 8
GT - Guatemala 8
IL - Israele 8
DZ - Algeria 7
KG - Kirghizistan 7
LB - Libano 7
NG - Nigeria 7
AL - Albania 6
CH - Svizzera 6
DO - Repubblica Dominicana 6
HU - Ungheria 6
JO - Giordania 6
PY - Paraguay 6
SV - El Salvador 6
BG - Bulgaria 5
PA - Panama 5
SI - Slovenia 5
A2 - ???statistics.table.value.countryCode.A2??? 4
EE - Estonia 4
EU - Europa 4
GH - Ghana 4
MD - Moldavia 4
OM - Oman 4
BH - Bahrain 3
BO - Bolivia 3
BZ - Belize 3
CI - Costa d'Avorio 3
GE - Georgia 3
NO - Norvegia 3
PR - Porto Rico 3
PS - Palestinian Territory 3
PT - Portogallo 3
RS - Serbia 3
SN - Senegal 3
YE - Yemen 3
AW - Aruba 2
Totale 75.279
Salva come PNG Salva come JPEG
Città #
Woodbridge 15.551
Wilmington 15.057
Houston 13.926
Singapore 1.637
Fairfield 1.633
Ashburn 1.575
Ann Arbor 1.432
Chandler 1.084
San Jose 867
Seattle 652
Jacksonville 597
Hong Kong 572
Cambridge 541
Dublin 513
Beijing 478
Medford 422
New York 407
Helsinki 368
Dallas 329
Council Bluffs 319
Santa Clara 305
The Dalles 302
Los Angeles 285
Rome 202
Lawrence 195
Dearborn 194
Lauterbourg 147
Ho Chi Minh City 138
Moscow 135
Zhengzhou 124
Hanoi 117
Tokyo 110
Buffalo 107
Chicago 103
São Paulo 100
Denver 86
Menlo Park 79
San Diego 79
Boardman 77
Milan 74
Mülheim 71
Redwood City 70
London 62
Toronto 61
Munich 54
Nanjing 53
Brussels 51
Phoenix 50
Shanghai 46
Atlanta 44
Norwalk 43
Brooklyn 42
Tauranga 42
Falls Church 41
North Bergen 41
Palo Alto 39
Seoul 39
Orem 37
Kraków 36
Nuremberg 36
Redondo Beach 35
Copenhagen 34
Amsterdam 33
Columbus 32
Naples 32
Stockholm 32
Warsaw 31
Chester 30
Johannesburg 30
Mountain View 30
Verona 30
Guangzhou 29
Hefei 29
Frankfurt am Main 28
Montreal 28
Shenzhen 28
Washington 28
Kunming 27
San Francisco 27
Chengdu 26
Jakarta 26
San Mateo 26
Melbourne 25
Suzhou 25
Philadelphia 24
University Park 24
Boston 22
Haiphong 22
Springfield 22
Taipei 22
Chennai 21
Las Vegas 21
Chongqing 20
Rio de Janeiro 19
Alexandria 17
Baghdad 17
Brasília 17
Jeddah 17
Detroit 16
Dong Ket 16
Totale 62.895
Salva come PNG Salva come JPEG
Nome #
Challenges in the treatment of Rheumatoid Arthritis 894
Serum thymosin α 1 levels in patients with chronic inflammatory autoimmune diseases 666
Complement, infection, and autoimmunity 608
Itch gene polymorphisms in healthy population and in patients affected by rheumatoid arthritis and atopic dermatitis 571
Complement and autoimmunity 549
Synovial fluid from patients with rheumatoid arthritis modulates monocyte cell-surface phenotype 544
Gonadal mosaicism in hereditary angioedema 538
Serum thymosin alpha 1 levels in normal and pathological conditions 537
Impact of a multidisciplinary approach in enteropathic spondyloarthritis patients 534
High levels of peripheral blood NK cells in women suffering from recurrent spontaneous abortion are reverted from high-dose intravenous immunoglobulins 532
Autoantibodies in inflammatory arthritis 524
A nationwide survey of hereditary angioedema due to C1 inhibitor deficiency in Italy 522
Intravenous immunoglobulin therapy in pregnant patients affected with systemic lupus erythematosus and recurrent spontaneous abortion 519
NK cells in autoimmunity: A two-edg'd weapon of the immune system 518
Peripheral blood natural killer cells and mild thyroid abnormalities in women with reproductive failure 518
Glutathione: A key player in autoimmunity 515
Vasculitides and the Complement System: a Comprehensive Review 514
C3 come indicatore di efficacia terapeutica in pazienti con artrite reumatoide in terapia con inibitori del TNFα 511
Stem cells in autoimmune diseases: Implications for pathogenesis and future trends in therapy 507
An impaired endothelial dependent and independent vasodilation characterizes the myo-endothelial dysfunction in ssc patients 506
Anti-thyroid antibodies and antiphospholipid syndrome: Evidence of reduced fecundity and of poor pregnancy outcome in recurrent spontaneous aborters 504
Efficacy and Safety of Subcutaneous Anti-Tumor Necrosis Factor-Alpha Agents, Etanercept and Adalimumab, in Elderly Patients Affected by Psoriasis and Psoriatic Arthritis: An Observational Long-Term Study 501
Differential expression of stromal cell-derived factor 1 and its receptor CXCR4 in the skin and endothelial cells of systemic sclerosis patients: Pathogenetic implications 499
Anti-TNFα discontinuation in rheumatoid and psoriatic arthritis: Is it possible after disease remission? 497
Evidence of impaired sense of smell in hereditary angioedema 496
Denaturing HPLC in laboratory diagnosis of hereditary angioedema 495
Normal fetal growth in women with antiphospholipid syndrome treated with high-dose intravenous immunoglobulin (IVIG) 494
Apremilast for the treatment of psoriasis. 493
The type I IFN system in rheumatoid arthritis 490
Adalimumab corrects long-term endothelial dysfunction in rheumatoid arthritis 489
Serological markers associated with disease activity in patients with rheumatoid arthritis treated with rituximab 485
Prolactin and natural killer cells: Evaluating the neuroendocrine-immune axis in women with primary infertility and recurrent spontaneous abortion 483
Evidence of IL-17 producing innate lymphoid cells in peripheral blood from patients with enteropathic spondyloarthritis 483
Remission and low disease activity in a cohort of real-life patients with rheumatoid arthritis treated with first-line antitumour necrosis factor 480
Expression of immunoglobulin-like transcript 4 as an inhibitory receptor in patients with psoriatic arthritis 480
Hereditary and acquired angioedema: Problems and progress: Proceedings of the third C1 esterase inhibitor deficiency workshop and beyond 479
High-dose intravenous immunoglobulin treatment activates complement in vivo 478
Role of the complement system in rheumatoid arthritis and psoriatic arthritis: Relationship with anti-TNF inhibitors 476
Long-term treatment with adalimumab in psoriatic arthritis: serum adalimumab concentration, immunogenicity and the link with clinical response 475
Golimumab in Patients Affected by Moderate to Severe Psoriatic Arthritis: An Open-Label Study in Thirty-Two Patients Previously Treated with Other Biologics 472
Complement system in rheumatoid arthritis: evidence of correlation with disease activity but not with anti-citrullinated protein antibodies 469
Profile of certolizumab and its potential in the treatment of psoriatic arthritis 469
Use of anti-tumor necrosis factor alpha therapy in patients with concurrent rheumatoid arthritis and hepatitis B or hepatitis C: a retrospective analysis of 32 patients 469
Polymorphisms in STAT4, PTPN2, PSORS1C1 and TRAF3IP2 genes are associated with the response to TNF inhibitors in patients with rheumatoid arthritis 469
Occurrence of localized scleroderma morphea in a patient with rheumatoid arthritis treated with etanercept 467
Sistema complementare e artrite reumatoide: Correlazioni con autoanticorpi, caratteristiche cliniche e di laboratorio e farmaci anti-TNF α 467
Self-reported adherence to a home-based exercise program among patients affected by psoriatic arthritis with minimal disease activity 467
Emergence of antinuclear antibodies in psoriatic patients treated with infliximab: personal experience and literature review 467
Recurrent Angioedema: Occurrence, Features, and Concomitant Diseases in an Italian Single-Center Study 467
Complement system in psoriatic arthritis: a useful marker in response prediction and monitoring of anti-TNF treatment. 465
Adalimumab and polymyalgia rheumatica. clinical remission but persisting high levels of esr: a controversy 465
The new era for the treatment of psoriasis and psoriatic arthritis: perspectives and validated strategies 465
Complement activation and sensitizing antibodies in lyme borreliosis - a microbial adherence immobilization assay for borrelia-burgdorferi (maia-bb) 464
Anti-Saccharomyces cerevisiae Autoantibodies in Autoimmune Diseases: from Bread Baking to Autoimmunity 464
Scleroderma heart involvement: non-invasive assessment of pathophysiological mechanism and its effect on prognosis 460
GM-CSF and pregnancy: Evidence of significantly reduced blood concentrations in unexplained recurrent abortion efficiently reverted by intravenous immunoglobulin treatment 458
Retinal functional changes measured by frequency-doubling technology in patients treated with hydroxychloroquine. 457
Antimyocardial Autoantibodies (AMCA) 452
ADA genetic polymorphism and total plasma IgE level in healthy adults 451
Metabolic profiling of human CD4+ cells following treatment with methotrexate and anti-TNF-α infliximab 451
Complement system and rheumatoid arthritis: relationships with autoantibodies, serological, clinical features, and anti-TNF treatment 450
The European register of hereditary angioedema: Experience and preliminary results 448
Small-medium vessel vasculitides: Is the complement system a potential forgotten target? 448
Prediction of early pregnancy maternal thyroid impairment in women affected with unexplained recurrent miscarriage. 447
Association of psoriasis and/or psoriatic arthritis with autoimmune diseases: The experience of two Italian integrated Dermatology/Rheumatology outpatient clinics 447
Evaluation of clinical and ultrasonographic parameters in psoriatic arthritis patients treated with adalimumab: a retrospective study 445
Auto-reactions, autoimmunity and psoriatic arthritis 444
HELLP syndrome: A complication or a new autoimmune syndrome? 442
Evidence-based recommendations for the therapeutic management of angioedema owing to hereditary C1 inhibitor deficiency: Consensus report of an International Working Group 442
TREATMENT OF RECURRENT SPONTANEOUS ABORTION WITH HIGH-DOSE INTRAVENOUS IMMUNOGLOBULIN 441
European consensus for gynecologycal and obstetric management of women with hereditary angioedema due to C1-inhibitor deficiency (HAE): PREHAEAT 441
The autoimmune side of hereditary angioedema: Insights on the pathogenesis 441
A 2-year observational study on treatment targets in psoriatic arthritis patients treated with TNF inhibitors 440
Functionally active complement is present in human ovarian follicular fluid and can be activated by seminal plasma. 439
Complement system in psoriatic arthritis: a useful marker and a potential therapeutic target of anti-tnf-alpha treatment 439
Inhibition of the complement system by glutathione: molecular mechanisms and potential therapeutic implications 437
Cytokine production by human fetal membranes and uterine decidua at term gestation in relation to labor 437
Behcet's disease and etanercept: eighty weeks of experience 436
'Autoimmunity cutting edge at the 21st century. Representation of the 9th international congress of autoimmunity, nice, France 2014' 434
Cystic ovaries in women affected with hereditary angioedema. 432
Immunomodulation in psoriatic arthritis: focus on cellular and molecular pathways 432
Hereditary and acquired angioedema: problems and progress: proceedings of the third C1 esterase inhibitor deficiency workshop and beyond 430
Downregulation of immunoglobulin-like transcript-4 (ILT4) in patients with psoriatic arthritis 428
The autoreactivity of B cells in hereditary angioedema due to C1 inhibitor deficiency 428
Successful high dose intravenous immunoglobulin treatment of a pregnant patient affected with hypereosinophilia syndrome and antiphospholipid syndrome (aPL plus recurrent spontaneous abortion) 427
Resolution with rituximab of localized scleroderma occurring during etanercept treatment in a patient with rheumatoid arthritis 427
NK cells, autoantibodies, and immunologic infertility: a complex interplay 426
Restoration of peripheral blood natural killer and B cell levels in patients affected by rheumatoid and psoriatic arthritis during etanercept treatment 426
BETA ENDORPHIN INTERACTION WITH LFA 1 (CD11A/CD18) ON HUMAN PERIPHERAL BLOOD LYMPHOCYTES 425
Resistance to apoptosis in circulating alpha/beta and gamma/delta T lymphocytes from patients with systemic sclerosis 424
Complement deficiency and antibody profile in survivors of meningococcal meningitis due to common serogroups in Italy 424
The interplay between inflammation and metabolism in rheumatoid arthritis 424
Remission of psoriatic arthritis after etanercept discontinuation: analysis of patients' clinical characteristics leading to disease relapse 423
Differential expression of SDF-1 and its receptor CXCR4 in the skin and endothelial cells of systemic sclerosis patients: Pathogenetic implication 422
Guidance for diagnosis and treatment of acute angioedema in the emergency department: consensus statement by a panel of Italian experts 422
Insights on the role of physical activity in patients with rheumatoid arthritis 422
Prediction of early pregnancy maternal thyroid impairment in women affected with unexplained recurrent miscarriage. 420
Hereditary angioneurotic edema: clinical and laboratory findings in 58 subjects 420
Comment on: Intravenous immunoglobulin therapy in pregnant patients affected with systemic lupus erythematosus and recurrent spontaneous abortion: reply 420
S100A8/A9 in psoriatic plaques from patients with psoriatic arthritis 420
Totale 47.459
Salva come PNG Salva come JPEG
Categoria #
all - tutte 173.502
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 173.502
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.594 0 0 0 118 84 128 101 99 101 198 180 585
2022/20232.649 239 229 97 368 252 581 204 162 264 38 153 62
2023/20241.026 132 41 48 35 84 317 29 106 19 26 16 173
2024/20254.597 181 980 493 273 105 304 214 181 436 412 581 437
2025/20268.672 592 335 1.086 824 814 384 1.207 939 868 780 433 410
2026/20272.978 441 399 1.604 534 0 0 0 0 0 0 0 0
Totale 76.056